Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells

Cédric Pastoret, Fabienne Desmots, Gaëlle Drillet, Simon Le Gallou, Marie-Laure Boulland, Alexia Thannberger, Anne-Violaine Doncker, Véronique Salaun, Gandhi Laurent Damaj, Richard Veyrat-Masson, Olivier Tournilhac, Aline Moignet, Céline Pangault, Mikaël Roussel, Thierry Fest, Thierry Lamy

Blood (2021) 137 (23): 3237–3250.

https://doi.org/10.1182/blood.2020006721

Published: 2021

Includes: Supplemental data

Journal Articles

Value of EVI1 Gene Expression Level in Adult Acute Lymphoblastic Leukemia (ALL): A Study from the Group for Research on Adult ALL (GRAALL)

Claire Abbal, Raouf Ben Abdelali, Marina Lafage, Françoise Huguet, Thibaut Leguay, Olivier Spertini, Nicolas Boissel, Claude Gardin, Carlos Graux, Jean-Michel Cayuela, Marie-Laure Boulland, Nathalie Grardel, Anne Bouvier, Michel Duchosal, MD, Véronique Lhéritier, Yves Chalandon, Vahid Asnafi, MDPhD, Norbert Ifrah, Hervé Dombret, MD PhD

Blood (2014) 124 (21): 1081.

https://doi.org/10.1182/blood.V124.21.1081.1081

Published: 2014

Journal Articles

Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia

Blood (2014) 123 (24): 3739–3749.

https://doi.org/10.1182/blood-2014-01-547695

Published: 2014

Includes: Supplemental data

Journal Articles

Two Years Follow-up Results of Graspall/Graall-SA2–2008 Study: L-Asparaginase-Loaded Red Blood Cell Combined with Standard EWALL Chemotherapy in Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (Ph-ALL)

Blood (2012) 120 (21): 1473.

https://doi.org/10.1182/blood.V120.21.1473.1473

Published: 2012

Journal Articles

Minimal Residual Disease At 3 Months, Combined to the Presence of IKZF1 Deletion in B-Lineage or Absence of NOTCH1 pathway Mutation in T-Lineage, Recapitulates the Disease Risk Assessment in Adults with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia - A GRAALL Study

Blood (2011) 118 (21): 572.

https://doi.org/10.1182/blood.V118.21.572.572

Published: 2011

Journal Articles

L-Asparaginase-Loaded Red Blood Cells Combined with Standard EWALL Chemotherapy in Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (Ph- ALL): First Results of the GRASPALL/GRAALL-SA2-2008 Study

Blood (2011) 118 (21): 2579.

https://doi.org/10.1182/blood.V118.21.2579.2579

Published: 2011

Journal Articles

Post-Induction Minimal Residual Disease (MRD) Defines a Large Subset of Adults with Favorable Ph-Negative Acute Lymphoblastic Leukemia (ALL), Who Do Not Benefit From Allogeneic Stem Cell Transplantation (SCT) in First Complete Remission: A GRAALL Study.

Blood (2009) 114 (22): 577.

https://doi.org/10.1182/blood.V114.22.577.577

Published: 2009

Journal Articles

Human IL4I1 is a secreted l-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation

Marie-Laure Boulland, Jeanine Marquet, Valérie Molinier-Frenkel, Peter Möller, Chrystelle Guiter, Fanette Lasoudris, Christiane Copie-Bergman, Maryse Baia, Philippe Gaulard, Karen Leroy, Flavia Castellano

Blood (2007) 110 (1): 220–227.

https://doi.org/10.1182/blood-2006-07-036210

Published: 2007

Journal Articles

Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma

Chrystelle Guiter, Isabelle Dusanter-Fourt, Christiane Copie-Bergman, Marie-Laure Boulland, Sabine le Gouvello, Philippe Gaulard, Karen Leroy, Flavia Castellano

Blood (2004) 104 (2): 543–549.

https://doi.org/10.1182/blood-2003-10-3545

Published: 2004

Journal Articles

Interleukin 4–induced gene 1 is activated in primary mediastinal large B-cell lymphoma

Christiane Copie-Bergman, Marie-Laure Boulland, Catherine Dehoulle, Peter Möller, Jean-Pierre Farcet, Martin J. S. Dyer, Corinne Haioun, Paul-Henri Roméo, Philippe Gaulard, Karen Leroy

Blood (2003) 101 (7): 2756–2761.

https://doi.org/10.1182/blood-2002-07-2215

Published: 2003

NARROW

Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells

Value of EVI1 Gene Expression Level in Adult Acute Lymphoblastic Leukemia (ALL): A Study from the Group for Research on Adult ALL (GRAALL)

Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia

Two Years Follow-up Results of Graspall/Graall-SA2–2008 Study: L-Asparaginase-Loaded Red Blood Cell Combined with Standard EWALL Chemotherapy in Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (Ph-ALL)

Minimal Residual Disease At 3 Months, Combined to the Presence of IKZF1 Deletion in B-Lineage or Absence of NOTCH1 pathway Mutation in T-Lineage, Recapitulates the Disease Risk Assessment in Adults with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia - A GRAALL Study

L-Asparaginase-Loaded Red Blood Cells Combined with Standard EWALL Chemotherapy in Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (Ph- ALL): First Results of the GRASPALL/GRAALL-SA2-2008 Study

Post-Induction Minimal Residual Disease (MRD) Defines a Large Subset of Adults with Favorable Ph-Negative Acute Lymphoblastic Leukemia (ALL), Who Do Not Benefit From Allogeneic Stem Cell Transplantation (SCT) in First Complete Remission: A GRAALL Study.

Human IL4I1 is a secreted l-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation

Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma

Interleukin 4–induced gene 1 is activated in primary mediastinal large B-cell lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only